Bill tracker, H.R. 1051, Health

To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Feb 6, 2025. Latest action Feb 6, 2025: Referred to the House Committee on Energy and Commerce.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentMarFeb 6, 2025: Introduced in HouseFeb 6, 2025: Referred to the House Committee on Energy and Commerce.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Full history

    • ReferredHouse. Referred to the House Committee on Energy and Commerce.
    • IntroducedIntroduced in House

Subjects

Drug safety, medical device, and laboratory regulationPrescription drugs

Read the bill on Congress.gov